Department of Radiation Oncology

Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment (2019) Seitz C, Ruckert M, Weiss EM, Utz S, Izydor M, Ebel N, Schlücker E, et al. Journal article, Original article Low-Dose Irradiation Differentially Impacts Macrophage Phenotype in Dependence of Fibroblast-Like Synoviocytes and Radiation Dose (2019) Fuchs J, Rueckert M, Fietkau R, Frey B, Gaipl U, Deloch L Journal article, Original article Time course of pain response and toxicity after whole-nerve-encompassing LINAC-based stereotactic radiosurgery for trigeminal neuralgia—a prospective observational study (2019) Koca S, Distel L, Lubgan D, Weissmann T, Lambrecht U, Lang-Welzenbach M, Eyüpoglu IY, et al. Journal article Rolle der Radiotherapie beim Pankreaskarzinom (2019) Goerig N, Fietkau R Journal article, Review article Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 (2019) Hofheinz R, Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, et al. Conference contribution Siponimod reduces perihemorrhagic edema and improves neurological outcome in experimental intracerebral hemorrhage (2019) Bobinger T, Manaenko A, Baeurele T, Seyler L, Nagel AM, Engelhorn T, Dörfler A, et al. Conference contribution Abstracts DEGRO 2019 Niedrig dosierte Röntgenstrahlung beeinflusst die Makrophagenpolarisation im Zusammenspiel mit Synovialfibroblasten auf eine anti-entzündliche Art und Weise (2019) Deloch L, Fuchs J, Rückert M, Frey B, Gaipl U Conference contribution Favorable radiation field decrease in gastric marginal zone lymphoma Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL) (2019) Reinartz G, Pyra RP, Lenz G, Liersch R, Stueben G, Micke O, Willborn K, et al. Journal article Chemoradiotherapy plus induction versus consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-12 multicentre, open-label, randomised, phase 2 trial (2019) Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution Leukocytosis and Neutrophilia as independent prognostic Biomarkers for clinical Outcome in the randomized Phase III CAO/ARO/AIO-04 Rectal Cancer Study (2019) Diefenhardt M, Hofheinz RD, Martin D, Beissbarth T, Arnold D, Hartmann A, Von Der Grun J, et al. Conference contribution